↓ Skip to main content

Comparative safety and efficacy of anti-PD-1 monotherapy, chemotherapy alone, and their combination therapy in advanced nasopharyngeal carcinoma: findings from recent advances in landmark trials

Overview of attention for article published in Journal for Immunotherapy of Cancer, June 2019
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
5 X users

Citations

dimensions_citation
58 Dimensions

Readers on

mendeley
63 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Comparative safety and efficacy of anti-PD-1 monotherapy, chemotherapy alone, and their combination therapy in advanced nasopharyngeal carcinoma: findings from recent advances in landmark trials
Published in
Journal for Immunotherapy of Cancer, June 2019
DOI 10.1186/s40425-019-0636-7
Pubmed ID
Authors

Jia-Wei Lv, Jun-Yan Li, Lin-Na Luo, Zi-Xian Wang, Yu-Pei Chen

X Demographics

X Demographics

The data shown below were collected from the profiles of 5 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 63 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 63 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 9 14%
Student > Ph. D. Student 9 14%
Student > Bachelor 6 10%
Other 4 6%
Student > Postgraduate 4 6%
Other 7 11%
Unknown 24 38%
Readers by discipline Count As %
Medicine and Dentistry 14 22%
Pharmacology, Toxicology and Pharmaceutical Science 5 8%
Agricultural and Biological Sciences 5 8%
Biochemistry, Genetics and Molecular Biology 4 6%
Nursing and Health Professions 2 3%
Other 4 6%
Unknown 29 46%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 July 2019.
All research outputs
#14,848,235
of 25,759,158 outputs
Outputs from Journal for Immunotherapy of Cancer
#2,404
of 3,509 outputs
Outputs of similar age
#179,847
of 367,507 outputs
Outputs of similar age from Journal for Immunotherapy of Cancer
#72
of 87 outputs
Altmetric has tracked 25,759,158 research outputs across all sources so far. This one is in the 41st percentile – i.e., 41% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,509 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 15.6. This one is in the 30th percentile – i.e., 30% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 367,507 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 50% of its contemporaries.
We're also able to compare this research output to 87 others from the same source and published within six weeks on either side of this one. This one is in the 14th percentile – i.e., 14% of its contemporaries scored the same or lower than it.